Cargando…

Potential Impact of the Z0011 Trial on the Omission of Axillary Dissection: A Retrospective Cohort Study

Objective To evaluate the number of patients with early-stage breast cancer who could benefit from the omission of axillary surgery following the application of the Alliance for Clinical Trials in Oncology (ACOSOG) Z0011 trial criteria. Methods A retrospective cohort study conducted in the Hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinzato, Julia Yoriko, Serra, Katia Piton, Eugeni, Caroline, Cabello, Cesar, Cardoso-Filho, Cassio, Zeferino, Luís Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183926/ https://www.ncbi.nlm.nih.gov/pubmed/33784760 http://dx.doi.org/10.1055/s-0041-1725052

Ejemplares similares

Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
por: Gebhardt, Brian J., et al.
Publicado: (2018)

Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
por: Radosa, Julia Caroline, et al.
Publicado: (2022)

Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis
por: Vale, Diama Bhadra, et al.
Publicado: (2019)

Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort
por: Jo, Heein, et al.
Publicado: (2020)

ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria
por: Radosa, Julia Caroline, et al.
Publicado: (2022)

Axillary Treatment Management in Breast Cancer during COVID-19 Pandemic (Association between ACOSOG Z0011 Criteria and OSNA Test)
por: Anedda, Giacomo, et al.
Publicado: (2023)

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?
por: Liu, Miao, et al.
Publicado: (2019)

Axillary Needle Biopsy in the Era of American College of Surgeons Oncology Group (ACOSOG) Z0011: Institutional Experience With a Largely Urban Minority Population and Review of the Literature
por: Choi, Lydia, et al.
Publicado: (2022)

Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis
por: Cha, Chihwan, et al.
Publicado: (2022)

Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020)

The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study
por: Liu, Miao, et al.
Publicado: (2015)

Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study
por: Peng, Yuan, et al.
Publicado: (2021)

Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
por: van Steenhoven, Julia E. C., et al.
Publicado: (2022)

Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
por: Jung, Jiwoong, et al.
Publicado: (2020)

Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)

Differences in breast cancer survival and stage by age in off-target screening groups: a population-based retrospective study
por: Fernandes, Juliana Oliveira, et al.
Publicado: (2023)

Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases
por: Spreafico, Fernanda Servidoni, et al.
Publicado: (2020)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Omission
Publicado: (1881)

An Omission
Publicado: (1885)

Omission
Publicado: (1867)

Omission
Publicado: (1882)

An Omission
Publicado: (1875)

Omission
Publicado: (1858)

Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era
por: Liang, Yue, et al.
Publicado: (2019)

Comparative study of surgical and oncological outcomes in oncoplastic versus non oncoplastic breast-conserving surgery for breast cancer treatment
por: Almeida, Natalie R., et al.
Publicado: (2021)

Omission of Affiliations
Publicado: (2019)

Omission in Supplement
Publicado: (2019)

Omission in Funding
Publicado: (2022)

Omission in Title
Publicado: (2022)

Omission of Subtitle
Publicado: (2022)

Managing the Axilla in Early Breast Cancer. Impact of ACOSOG Z0011 Trial in Changing Practices in a Low Middle Income Country
por: Malik, Awais Amjad, et al.
Publicado: (2017)

Effect of non-sentinel metastasis on adjuvant treatment decisions and survival in Z0011 eligible non-screened detected breast cancer population
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2021)

Salient omissions—pupil dilation in response to unexpected omissions of sound and touch
por: Dercksen, Tjerk T., et al.
Publicado: (2023)

Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer: A Population-Based Cohort Study
por: Castelo, Matthew, et al.
Publicado: (2022)

Omission in Funding/Support
Publicado: (2020)

Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
por: Qu, Fei-Lin, et al.
Publicado: (2022)

Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer
por: Silva, Leonardo Roberto da, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n817vje3ts644ul8mjlv2t60pg